XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Note 13 - Earnings Per Share
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 13: EARNINGS PER SHARE

 

Basic earnings per share computations are based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share computations include any dilutive effect of potential common shares. In periods with a net loss available to common shareholders, diluted earnings per share are calculated using weighted-average basic shares for that period, as utilizing diluted shares would be anti-dilutive to loss per share.

 

A reconciliation of the amounts used to calculate basic and diluted earnings per share for the three months ended March 31, 2024 and 2023 follows:

 

   

Three Months Ended

 
   

March 31,

 

(in millions)

 

2024

   

2023

 

Net earnings

  $ 32     $ 33  

Less: Series B Preferred stock cash dividends

    (1 )     (1 )

Less: Series C Preferred stock in-kind dividends

    (1 )     (1 )

Less: Preferred stock deemed dividends

    (1 )     (1 )

Less: Earnings attributable to Series C Preferred shareholders

    (4 )     (4 )

Net earnings available to common shareholders - basic

  $ 25     $ 26  
                 

Effect of dilutive securities:

               

Add back: Series B preferred stock cash and deemed dividends

  $ 2     $ 1  

Add back: Convertible Notes interest expense

          1  

Net earnings available to common shareholders - diluted

  $ 27     $ 28  

 

   

Three Months Ended

 
   

March 31,

 

(in millions of shares)

 

2024

   

2023

 

Weighted average shares — basic

    79.7       79.1  

Effect of dilutive securities

               

Employee stock options

    0.6       0.4  

Unvested restricted stock units

    1.5       0.7  

Series B Preferred Stock

    9.5       9.5  

Convertible Notes

          2.5  

Weighted average shares — diluted

    91.3       92.2  

 

The computation of diluted earnings per share for the three months ended March 31, 2024 excluded the impact of (1) the assumed conversion of 1.2 million shares of Series C Preferred Stock, (2) the assumed vesting of 0.1 million unvested restricted stock units and (3) the assumed exercise of 3.9 million outstanding employee stock options because the effects would have been anti-dilutive. 

 

The computation of diluted earnings per share for the three months ended March 31, 2023 excluded the impact of (1) the assumed conversion of 1.1 million shares of Series C Preferred Stock, (2) the assumed vesting of 0.1 million unvested restricted stock units and (3) the assumed exercise of 4.3 million outstanding employee stock options because the effects would have been anti‐dilutive.